Other

Alitair Pharmaceuticals Inc

Russell Francis Somma

William Wayne Howard

Sheldon Kavesh

Pravin Megharji Bhutada

Ashish Ashokkao Deshmukh

Hemant Hanumant Bhalerao

Sajeev Chandran

Doreen Marie Frank

A method and compositions for treating a patient that prevent or reduce drug abuse and overdose events.

Preventing or reducing drug abuse and overdose events

Benzonatate resinates of weak acid ion exchange resins having the same distribution of butyl 4-aminobenzoate homologs as exist in the benzonatate listed in the F.D.A. Orange Book as Application No. N011210. These resinates, in simulated gastrointestinal dissolution, release essentially the same distribution of butyl-4 aminobenzoate homologs as exist in the benzonatate listed in the F.D.A. Orange Book as Application No. N011210.

Benzonatate compositions and methods of use

Multi-layer solid oral dosage immediate release and extended release compositions and methods for delivering drug formulations using weak acid ion exchange resins in abnormally high pH environments.

Immediate release compositions and methods for delivering drug formulations using weak acid ion exchange resins in abnormally high pH environments

Oral dosage forms of benzonatate useful for anti-tussive and anti-tussive/combination applications.

Immediate release compositions and methods for delivering drug formulations using weak acid ion exchange resins in abnormally high pH environments.

Growing community of inventors

Sparta, NJ, United States of America

Russell Francis Somma